Activation of distinct subsets of T suppressor cells with type III pneumococcal polysaccharide coupled to syngeneic spleen cells.
D000818:Animals; D000921:Antibody-Producing Cells / Q000276:immunology; D000950:Antigens, Ly / Q000276:immunology; D000961:Antilymphocyte Serum / Q000494:pharmacology; D003520:Cyclophosphamide / Q000494:pharmacology; D005260:Female; D006462:Hemolytic Plaque Technique; D000949:Histocompatibility Antigens Class II / Q000276:immunology; D007108:Immune Tolerance; D008213:Lymphocyte Activation; D051379:Mice; D008805:Mice, Inbred A; D008807:Mice, Inbred BALB C; D010641:Phenotype; D011135:Polysaccharides, Bacterial / Q000276:immunology*; D013154:Spleen / Q000166:cytology / Q000276:immunology; D050378:T-Lymphocytes, Regulatory / Q000276:immunology*; D013934:Thymectomy
D000950:Antigens, Ly; D000961:Antilymphocyte Serum; D000949:Histocompatibility Antigens Class II; D011135:Polysaccharides, Bacterial; C026604:pneumococcal polysaccharide, type III; D003520:Cyclophosphamide